凉血解毒方治疗银屑病的系统药理学与实验验证研究
该研究采用系统药理学、代谢组学和实验验证方法,从凉血解毒方12味中药中鉴定出144个具有良好药代动力学性质的活性化合物,关联125个银屑病相关靶蛋白。在IMQ诱导的小鼠银屑病样模型中验证了该方改善皮损、抑制角质形成细胞增殖、改善分化、抑制CD3+ T细胞浸润,并通过抑制MAPK、PI3K/AKT和NF-κB信号通路减少炎症因子表达。银屑病患者血清代谢组学显示该方改善甘油磷脂代谢和类固醇激素生物合成两条代谢通路。
要点
- 凉血解毒方通过多成分-多靶点-多通路协同发挥抗银屑病作用。
- 该方可抑制MAPK、PI3K/AKT和NF-κB信号通路减轻炎症。
- 该方改善甘油磷脂代谢和类固醇激素生物合成代谢紊乱。
核心结论
- 凉血解毒方通过多维度机制发挥抗银屑病作用,涉及抑制角质形成细胞增殖、改善分化、抑制T细胞浸润及炎症信号通路。
- 该方还可调节甘油磷脂代谢和类固醇激素生物合成两条代谢通路。
研究设计与样本
- 采用系统药理学ADME分析、网络构建、IMQ诱导小鼠银屑病样模型实验验证及银屑病患者血清LC-MS代谢组学分析。
- 从凉血解毒方12味中药中鉴定出144个活性化合物,关联125个银屑病相关靶蛋白。
主要发现
- 凉血解毒方改善IMQ诱导的小鼠银屑病样皮损,抑制角质形成细胞增殖,改善角质形成细胞分化,抑制CD3+ T细胞浸润。
- 与模型组相比,凉血解毒方显著降低IL-1β、IL-6、TNF-α、Cox2等炎症因子表达,抑制p-P65、p-IκB、p-ERK、p-P38、p-PI3K、p-AKT磷酸化。
- 银屑病患者血清代谢组学显示该方改善甘油磷脂代谢和类固醇激素生物合成两条扰动代谢通路。
临床怎么用
- 凉血解毒方可作为银屑病的中医治疗选择,其作用机制涉及多靶点抗炎和代谢调节。
- 临床可结合患者炎症状态和代谢紊乱情况考虑使用该方。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Clinical studies have demonstrated the anti-psoriatic effect of the LiangXueJieDu (LXJD) herbal formula. However, the systemic mechanism and the targets of the LXJD formula have not yet been elucidated. In the present study, a systems pharmacology approach, metabolomics, and experimental evaluation were employed. First, by systematic absorption-distribution-metabolism-excretion (ADME) analysis, 144 active compounds with satisfactory pharmacokinetic properties were identified from 12 herbs of LXJD formula using the TCMSP database. These active compounds could be linked to 125 target proteins involved in the pathological processes underlying psoriasis. Then, the networks constituting the active compounds, targets, and diseases were constructed to decipher the pharmacological actions of this formula, indicating its curative effects in psoriasis treatment and related complications. The psoriasis-related pathway comprising several regulatory modules demonstrated the synergistic mechanisms of LXJD formula. Furthermore, the therapeutic effect of LXJD formula was validated in a psoriasis-like mouse model. Consistent with the systems pharmacology analysis, LXJD formula ameliorated IMQ-induced psoriasis-like lesions in mice, inhibited keratinocyte proliferation, improved keratinocyte differentiation, and suppressed the infiltration of CD3+ T cells. Compared to the model group, LXJD formula treatment remarkably reduced the expression of inflammatory cytokines and factors, such as IL-1β, IL-6, TNF-α, Cox2, and inhibited the phosphorylation of p-P65, p-IқB, p-ERK, p-P38, p-PI3K, p-AKT, indicating that LXJD formula exerts its therapeutic effect by inhibiting the MAPK, PI3K/AKT, and NF-қB signaling pathways. The metabolic changes in the serum of psoriasis patients were evaluated by liquid chromatography coupled with orbitrap mass spectrometry (LC-MS). The LXJD formula improved two perturbed metabolic pathways of glycerophospholipid metabolism and steroid hormone biosynthesis. Overall, this study revealed the complicated anti-psoriatic mechanism of LXJD formula and also offered a reliable strategy to elucidate the complex therapeutic mechanism of this Chinese herbal formula in psoriasis from a holistic perspective.
引用
- Zhao J, Wang Y, Chen W, et al. Systems Pharmacology Approach and Experiment Evaluation Reveal Multidimensional Treatment Strategy of LiangXueJieDu Formula for Psoriasis. Front Pharmacol. 2021. PMID: 34168554. doi:10.3389/fphar.2021.626267
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。